Slide 1: Bliss GVS Pharma Ltd. exchange cover letter
BLISS GVS PHARMA LTO. . May 21, 2019 To To The Manager, Listing Deparhnent The General Manager, Listing Department National Stock Exchange of India BSE Limited Plot no. c/: G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East), Dalal Street, Mumbai- 400 051 Mumbai- 400001 Symbol: B
Slide 2: Earnings Presentation Q4-FY19/FY19
EARNINGS PRESENTATION Q4-FY19/FY19
Slide 3: Executive Summary
Executive Summary OVERVIEW Incorporated in 1984, Bliss GVS Pharma Ltd., has more than 34 years of expertise in manufacturing, marketing & exporting of more than 250 Branded Formulations in various dosage forms with a major focus on the Sub-Sahara African region. It is a world leader in Supposito
Slide 4: Q4-FY19 Financial Highlights
Q4-FY19 Financial Highlights Q4-FY19 Performance (Standalone): FY19 Performance (Standalone): • Operational Income: INR 1,061 Mn • Operational Income: INR 4,266 Mn • EBITDA: INR 139 Mn • EBITDA: INR 931 Mn • EBITDA Margin: 13.10% • EBITDA Margin: 21.82% • Net Profit: INR 46 Mn • Net Profit: INR
Slide 5: Q4-FY19 Operational Highlights
Q4-FY19 Operational Highlights Standalone - Operational Highlights Increase in standalone operational revenue by INR 1,283 Mn (43%) was on account of increase in the export business mainly to Nigeria, Ghana, France, DR Congo and Kenya etc. for the year ended March 2019. The increase in sales was
Slide 6: Quarterly - Standalone Income Statement (Ind-AS)
Quarterly - Standalone Income Statement (Ind-AS) PARTICULARS (INR Mn) Q4-FY19 Q4-FY18 Y-o-Y Q3-FY19 Q-o-Q Operational Revenue 1,061 833 27.4% 956 11.0% Total Expenses 922 549 67.9% 710 29.9% EBITDA 139 284 (51.1)% 246 (43.5)% EBITDA Margins (%) 13.10% 34.09% NA 25.73% NA Depreciation 14 14 NA 13 7.7
Slide 7: Standalone Income Statement (Ind-AS)
Standalone Income Statement (Ind-AS) PARTICULARS (INR Mn) FY19 FY18 Y-o-Y Operational Revenue 4,266 2,983 43.0% Total Expenses 3,335 2,098 59.0% EBITDA 931 885 5.2% EBITDA Margins (%) 21.82% 29.67% (785) Bps Depreciation 57 57 NA Finance Cost 32 70 (54.3)% Other Income 358 110 225.5% PBT 1,200 868 3
Slide 8: Quarterly - Consolidated Income Statement (Ind-AS)
Quarterly - Consolidated Income Statement (Ind-AS) PARTICULARS (INR Mn) Q4-FY19 Q4-FY18* Y-o-Y Q3-FY19 Q-o-Q Operational Revenue 2,441 1,671 46.1% 2,204 10.8% Total Expenses 2,121 1,296 63.7% 1,769 19.9% EBITDA 320 375 (14.7)% 435 (26.4)% EBITDA Margins (%) 13.11% 22.44% (933) Bps 19.74% (663) Bps D
Slide 9: Consolidated Income Statement (Ind-AS)
Consolidated Income Statement (Ind-AS) PARTICULARS (INR Mn) FY19* FY18* Y-o-Y Operational Revenue 8,982 8,151 10.2% Total Expenses 7,406 6,180 19.8% EBITDA 1,576 1,971 (20.0)% EBITDA Margins (%) 17.55% 24.18% (663) Bps Depreciation and Amortisation Expense 89 213 (58.2)% Finance Costs 44 228 (80.7)%
Slide 10: Historical Standalone Income Statement
Historical Standalone Income Statement PARTICULARS (INR Mn) FY16 FY17* FY18* FY19* Operational Revenue 3,264 3,503 2,983 4,266 Total Expenses 2,299 2,493 2,098 3,335 EBITDA 965 1,010 885 931 EBITDA Margins (%) 29.56% 28.83% 29.67% 21.82% Depreciation 59 56 57 57 Finance Cost 135 91 70 32 Other Incom
Slide 11: Standalone Balance Sheet (Ind-AS)
Standalone Balance Sheet (Ind-AS) PARTICULARS (INR Mn) FY17 FY18 FY19 PARTICULARS (INR Mn) FY17 FY18 FY19 EQUITIES & LIABILITIES ASSETS Non-current Assets 1,115 1,177 1,579 Shareholder Funds 4,916 5,414 6,033 (A) Property, Plant and Equipment 750 720 779 (A) Share Capital 103 103 103 (B) Capital Wor
Slide 12: Historical Consolidated Income Statement (Ind-AS)
Historical Consolidated Income Statement (Ind-AS) PARTICULARS (INR Mn) FY16 FY17* FY18* FY19* Operational Revenue 5,469 8,024 8,151 8,982 Total Expenses 3,912 5,996 6,180 7,406 EBITDA 1,557 2,028 1,971 1,576 EBITDA Margins (%) 28.47% 25.27% 24.18% 17.55% Depreciation and Amortisation Expense 186 197
Slide 13: Consolidated Balance Sheet (Ind-AS)
Consolidated Balance Sheet (Ind-AS) PARTICULARS (INR Mn) FY17 FY18 FY19 PARTICULARS (INR Mn) FY17 FY18 FY19 EQUITIES & LIABILITIES ASSETS Shareholder Funds 4,866 5,362 6,460 Non-current Assets 4,570 1,702 2,113 (A) Share Capital 103 103 103 (A) Property, Plant and Equipment 2,549 1,263 1,348 (B) Oth
Slide 14: Standalone Financial Highlights
Standalone Financial Highlights Operational Revenue (INR Mn) EBITDA (INR Mn) & EBITDA Margins PAT (INR Mn) & PAT Margins 5,000 1400 800 1200 700 4,000 1000 600 19% 18% 3,000 800 30% 29% 30% 16% 16% 22% 500 2,000 600 400 400 1,000 300 200 3,264 3,503 2,983 4,266 965 1,010 885 931 656 591 570 744 0 0
Slide 15: Consolidated Financial Highlights
Consolidated Financial Highlights Operational Revenue (INR Mn) EBITDA (INR Mn) & EBITDA Margins PAT (INR Mn) & PAT Margins 10,000 2,500 1,400 8,000 2,000 1,200 28% 25% 24% 1,000 6,000 1,500 18% 18% 800 14% 14% 4,000 1,000 11% 600 2,000 500 400 5,469 8,024 8,151 8,982 1,557 2,028 1,971 1,576 1,001 1,
Slide 16: Market Data
Market Data Share Price Data as on 31st March, 2019 Bliss Sensex 40% 30% 20% 10% 0% -10% -20% -30% -40% Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 Price Data (31st March, 2019) INR Shareholding Pattern Shareholding as as Pattern 30th31June, on on 20172019 st
Slide 17: Disclaimer
Disclaimer No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the d